Gr. Sarantis S.a. · ATHEX:SAR
Gr. Sarantis — Sarantis Group — Investor Presentation (November 2025)
30 slides from Gr. Sarantis's investor presentation, November 2025
Slide 1: Sarantis Group Investors Presentation November 2025
Sarantis Group Investors Presentation November 2025
Slide 2: Forward-looking statement
Forward-looking statement This document contains certain “forward-looking” statements. These statements may generally, but not always, be identified by the use of words such as “outlook”, “forecast”, “objective”, “expect”, “plan”, “intend”, “anticipate”, “believe”, “target”, “will”, “aim” and other
Slide 3: A long history of 60 years
A long history of 60 years 2015 Milestone acquisitions: 1964 Establishment of 1994 New production facilities Polipak, Ergopack, Stella GR. SARANTIS S.A. 2000 in Athens 2024 Pack Expansion in Eastern Investments in Europe infrastructure New exclusive strategic agreements Intense Acquisition Listed on
Slide 4: We care for the future the same way we care about the present
We care for the future the same way we care about the present OUR COMPETITIVE ADVANTAGE OUR SCOPE ▪ We design for the CEE region with deep local consumer understanding ▪ CEE and selected international markets on beauty ▪ We are the revitalisers of local “jewel” brands ▪ Home Care solutions ▪ We inve
Slide 5: Consistent organic growth with acquisitions coming on top
Consistent organic growth with acquisitions coming on top Sarantis Group Growth Drivers Beauty, Skin & Personal Home Care Strategic Sun Care Care Solutions Partnerships Disproportionate Core Profit Significant growth driver Market leverage growth Generator Complementary acquisitions on top in key pr
Slide 6: Accelerating our international expansion momentum
Accelerating our international expansion momentum Expansion of international markets portfolio Growth Drivers for Exports USA #1 in Tanning Category at Oils and Lotions Beauty, Skin & Suncare in Amazon US #100 in Beauty and Personal Care Category in Amazon US (among 70,000+ brands) Launched with phy
Slide 7: Executing our strategic transformation agenda
Executing our strategic transformation agenda DIGITAL TRANSFORMATION MANUFACTURING UPGRADE ESG ▪ New SAP implementation: Building ▪ Stella Pack regranulation upgrade to drive efficiency, sustainability and cost ▪ Validate near-term climate targets a unified data platform across markets savings: €15m
Slide 8: Solid nine-month performance with continued profitability growth
Solid nine-month performance with continued profitability growth 9m 2025 Net Sales € 448.5m - 0.8%* *Net sales impacted by the sale of Stella Pack Ukraine: like-for-like variance: -0.3% 9m 2025 EBITDA 9m 2025 EBIT Robust Financial Position € 68.0m € 51.7m Net debt € 4.9m + 7.9% + 7.4% as of Septembe
Slide 9: H1 2025 solid sales with strong delivery in profitability
H1 2025 solid sales with strong delivery in profitability Consolidated Statement of Comprehensive income Amounts In €m H1 2025 H1 2024 Δ (unless otherwise stated) Net Sales 304.3 302.6 0.5% Gross Profit 117.5 116.8 0.6% Gross Profit margin 38.6% 38.6% EBITDA 48.3 41.7 15.7% EBITDA margin 15.9% 13.8%
Slide 10: Strong profitability in strategic growth category, rebalancing Private Label portfolio
Strong profitability in strategic growth category, rebalancing Private Label portfolio H1 2025 figures NET SALES EBIT EBIT % % Δ y-o-y % Δ y-o-y Δ y-o-y Beauty, Skin € 55.0m € 15.9m 28.9% & Sun Care + 22.7% + 71.6% + 824bps Personal € 50.7m € 8.5m 16.7% Care - 3.5% + 13.3% + 248bps Home Care € 101.7
Slide 11: Strong growth in key markets while navigating a mixed consumer environment
Strong growth in key markets while navigating a mixed consumer environment H1 2025 figures NET SALES EBIT EBIT% %Δ y-o-y %Δ y-o-y Δ y-o-y NET SALES EBIT EBIT% %Δ y-o-y %Δ y-o-y Δ y-o-y € 97.6m € 19.3m 19.8% Greece € 97.6m € 19.3m 19.8% + 9.9% + 56.0% + 585bps Greece + 9.9% + 56.0% + 585bps € 89.9m €
Slide 12: Strong balance sheet
Strong balance sheet ▪ Balance sheet empowers financial strength and flexibility to ▪ invest organically ▪ support the transformation of the Group ▪ fuel M&A activity ▪ Stable financial position with net debt of €32.8m as of 30.06.2025 (net debt of €43.9m as of 30.06.2024) ▪ Receipt of first instalm
Slide 13: Enhancing shareholders value
Enhancing shareholders value Dividend paid in May 2025 €20.0m (+33.3% to PY) €0.31 per share EPS €0.4575 Dividend payout ratio 43.5% per share (vs 38.2% in the PY) (+ 22.2%) Share buy-back Cancelation of program treasury stocks in place as of June 19th, 2025 13 Sarantis Group Investors Presentation
Slide 14: CAPEX Execution Plan with increased investment from 2025
CAPEX Execution Plan with increased investment from 2025 Capex 2024 2025 2026 2027 2028 Oinofyta DC* € 1.5m € 23.5m Digital* € 4.0m € 3.0m € 6.0m transformation Stella € 3.0m € 15.0m € 3.0m € 2.0m € 2.0m Rest of Group € 8.5m € 14.0m € 6.0m € 6.0m € 6.0m Total € 17.5m € 34.5m € 35.5m € 8.0m € 8.0m 5-
Slide 15: 2025 outlook update
2025 outlook update as indicated in 9m 2025 trading update We reiterate our 2025 profitability guidance EBITDA at €92.0m EBIT at €70.0m + 12.7% vs 2024 + 14.8% vs 2024 15 Sarantis Group Investors Presentation
Slide 16: ESG Strategy
ESG Strategy
Slide 17: Raising Corporate Governance Standards
Raising Corporate Governance Standards New Board of Directors * Executive Directors Long-term incentive scheme updated: ✓ 4 Executive Directors * ✓ Running in three-year performance cycles Kyriakos Sarantis, Chairman of the ✓ Targets for 2023-2025 & 2024-2026 cycles: EBITDA margin, ✓ 6 Non-Executive
Slide 18: Committing to Science-Based Targets initiative (SBTi)-aligned targets
Committing to Science-Based Targets initiative (SBTi)-aligned targets We align our strong financial performance with measurable sustainability initiatives that drive business value 2023 2026 2027 2030 2050 we commit to setting a we commit to Net-zero mid-term CO2 scope 3 carbon footprint across the
Slide 19: Appendix
Appendix
Slide 20: Delivering Strong Shareholder Value
Delivering Strong Shareholder Value 5-Year Plan* *as communicated during the Investor Day in March 2024
Slide 21: Doubling the EBITDA Organically in the next 5 years
Doubling the EBITDA Organically in the next 5 years (€m) 2023 2024* 2025 2026 2027 2028 Net Sales 482.2 595.2 627.9 662.5 698.9 737.4 %YoY 23.5% 5.5% 5.5% 5.5% 5.5% Gross Margin 182.0 225.1 239.3 254.5 270.6 287.6 % on NS 37.8% 37.8% 38.1% 38.4% 38.7% 39.0% A&P 28.6 33.9 37.2 40.6 41.5 42.4 % on NS
Slide 22: Investing for our future – Capex
Investing for our future – Capex as per Investor Day, March 14, 2024 Capex 2024 2025 2026 2027 2028 Oinofyta DC* € 7.0m € 18.0m Digital* € 5.0m € 4.0m € 3.0m transformation Stella € 3.0m € 6.0m € 5.0m € 2.0m € 2.0m Rest of Group € 5.0m € 5.0m € 4.0m € 6.0m € 6.0m Total € 20.0m € 33.0m € 12.0m € 8.0m
Slide 23: A business with Strong Free Cash Flow generation
A business with Strong Free Cash Flow generation € million 2023 2024 2025 2026 2027 2028 EBITDA 61.6 80.2 90.3 100.5 110.3 120.2 Tax 9.6 10.2 11.5 13.3 14.9 16.5 Working capital change (7.2) 14.1 0.8 (0.6) 0.4 2.2 Capex 7.3 20.0 33.0 12.0 8.0 8.0 Estee Lauder Sale Receivable 20.6 20.6 FCF 51.9 35.9
Slide 24: Why Sarantis has a strong Investment Case
Why Sarantis has a strong Investment Case ▪ Sustainable organic growth engine 01 ▪ Leading presence in our geographies ▪ Strong brand portfolio in the right categories ▪ Strong supply chain footprint with continuous investment plan 2X EBITDA in 5 years from 2023 ▪ 02 ▪ Consistent dividend ~ 38% or m
Slide 25: Our brands
Our brands Beauty, Skin & Sun Care Personal Care
Slide 26: Our brands – Home Care Solutions
Our brands – Home Care Solutions
Slide 27: Strategic Partnerships – Mass Distribution
Strategic Partnerships – Mass Distribution
Slide 28: Strategic Partnerships – Selective Distribution
Strategic Partnerships – Selective Distribution
Slide 29: Recent Acquisitions
Recent Acquisitions 2014 2015 2015 2018 2018 2020 2024 Before Acquisition Before Acquisition Before Acquisition Before Acquisition Before Acquisition Before Acquisition Before Acquisition ✓ Cosmetics brand ✓ Hand-dishwashing ✓ Production of PL ✓ Cosmetics brand ✓ Leading player in the ✓ Cosmetics br
Slide 30: Q & A
Q&A For further information on Sarantis Group please visit our website at https://sarantisgroup.com/ or contact our Investor Relations team: Eleni Moustakidou Investor Relations Manager emoustakidou@sarantisgroup.com +30 210 6173065
Sarantis Group — Investor Presentation (November 2025) on 6ix